Search Results 301-310 of 994 for ���������������������������������������������:PC90���

  1. Olaparib Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.

  3. Publications - Paul E. Croarkin, D.O., M.S. - Mayo Clinic

    Buyuktaskin D, Lewis CP, Nakonezny PA, Delaney K, Sangster-Carrasco L, Romanowicz M, Shekunov J, Zaccariello MJ, Vande Voort JL, Croarkin PE.

  4. A Study to Assess the Effectiveness and Safety of Intravitreal 440 ug DE-109 Sirolimus Injections for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye - Mayo Clinic

    A Study to Assess the Effectiveness and Safety of Intravitreal 440 ug DE-109 Sirolimus Injections for the Treatment of Active, Non-Infectious Uveitis of the ...

  5. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

    PI3K-delta inhibitor TGR-1202 may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Biological therapies, such as ...

  6. Parkinson's Clinical Trials - Mayo Clinic Research

    The purpose of this study is to provide feasibility data for a novel method of defining patient-specific functional anatomic targets for Globus Pallidus ...

  7. Medical Research & Education - Mayo Clinic News Network

    JACKSONVILLE, Fla. — Mayo Clinic's pioneering exploration of stem cell-based therapies for bone loss is headed to space. Abba Zubair, M.D., Ph.D., ...

  8. A Study of the Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) - Mayo Clinic

    About this study. The purpose of this study is to demonstrate the superiority of MD1003 (300 mg/day) over placebo to clinically improve patients with ...

  9. A Study to Assess the Effectiveness, Safety, Tolerability, and Drug/Body Interactions of ABBV-8E12 in Progressive Supranuclear Palsy - Mayo Clinic

    The purpose of this study is to assess the effectiveness, safety, tolerability, and drug/body interactions of ABBV-8E12 for the treatment of patients who have ...

  10. Science Saturday - 2025 Archives - Mayo Clinic News Network

    No posts available. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery Science · Healthcare Delivery ...